136
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Predicting the risk of fetal macrosomia at pregnancy in Shandong province: a case-control study

, , , , , & show all
Pages 6260-6266 | Received 20 May 2020, Accepted 26 Mar 2021, Published online: 18 Apr 2021

References

  • Beta J, Khan N, Khalil A, et al. Maternal and neonatal complications of fetal macrosomia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54(3):308–318.
  • Duan S, Zhang M, Li J, et al. Uterine metabolic disorder induced by silica nanoparticles: biodistribution and bioactivity revealed by labeling with FITC. J Nanobiotechnology. 2021;19(1):62.
  • Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290–e296.
  • Chatfield J. ACOG issues guidelines on fetal macrosomia. American College of Obstetricians and Gynecologists. Am Fam Physician. 2001;64(1):169–170.
  • Fang F, Zhang QY, Zhang J, et al. Risk factors for recurrent macrosomia and child outcomes. World J Pediatr. 2019;15(3):289–296.
  • Jeffers E, Dodds L, Allen V, et al. Predicting the risk of macrosomia at mid-pregnancy among non-diabetics: a retrospective cohort study. J Obstet Gynaecol Can. 2017;39(12):1129–1136.
  • Jolly MC, Sebire NJ, Harris JP, et al. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111(1):9–14.
  • Kurmanavicius J, Burkhardt T, Wisser J, et al. Ultrasonographic fetal weight estimation: accuracy of formulas and accuracy of examiners by birth weight from 500 to 5000 g. J Perinat Med. 2004;32(2):155–161.
  • Li G, Kong L, Li Z, et al. Prevalence of macrosomia and its risk factors in China: a multicentre survey based on birth data involving 101,723 singleton term infants. Paediatr Perinat Epidemiol. 2014;28(4):345–350.
  • Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for. Natl Vital Stat Rep. 2004;55(1):1–101.
  • Nahum GG. Predicting fetal weight. Are Leopold's maneuvers still worth teaching to medical students and house staff? J Reprod Med. 2002;47(4):271–278.
  • Onwude JL, Rao S, Selo-Ojeme DO. Large babies and unplanned Caesarean delivery. Eur J Obstet Gynecol Reprod Biol. 2005;118(1):36–39.
  • Onyiriuka AN. High birth weight babies: incidence and foetal outcome in a mission hospital in Benin City, Nigeria. Niger J Clin Pract. 2006;9(2):114–119.
  • Perni SC, Predanic M, Cho JE, et al. Association of amniotic fluid index with estimated fetal weight. J Ultrasound Med. 2004;23(11):1449–1452.
  • Pongcharoen T, Gowachirapant S, Wecharak P, et al. Pre-pregnancy body mass index and gestational weight gain in Thai pregnant women as risks for low birth weight and macrosomia. Asia Pac J Clin Nutr. 2016;25(4):810–817.
  • Rao J, Fan D, Wu S, et al. Trend and risk factors of low birth weight and macrosomia in south China, 2005–2017: a retrospective observational study. Sci Rep. 2018;8(1):3393.
  • Said AS, Manji KP. Risk factors and outcomes of fetal macrosomia in a tertiary centre in Tanzania: a case-control study. BMC Pregnancy Childbirth. 2016;16(1):243.
  • Souka AP, Papastefanou I, Pilalis A, et al. Performance of the ultrasound examination in the early and late third trimester for the prediction of birth weight deviations. Prenat Diagn. 2013;33(10):915–920.
  • Suzuki S. Association between maternal weight and infant macrosomia in Japan. J Matern Fetal Neonatal Med. 2018;31(3):404–405.
  • Walsh JM, McAuliffe FM. Prediction and prevention of the macrosomic fetus. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):125–130.
  • Wang D, Hong Y, Zhu L, et al. Risk factors and outcomes of macrosomia in China: a multicentric survey based on birth data. J Matern Fetal Neonatal Med. 2017;30(5):623–627.
  • Duan S, Zhang M, Sun Y, et al. Mechanism of PM2.5-induced human bronchial epithelial cell toxicity in central China. J. Hazard. Mater. 2020;396:122747.
  • Yang W, Liu J, Li J, et al. Interactive effects of prepregnancy overweight and gestational diabetes on macrosomia and large for gestational age: a population-based prospective cohort in Tianjin, China. Diabetes Res Clin Pract. 2019;154:82–89.
  • Tian J, Li J, Yin H, et al. In vitro and in vivo uterine metabolic disorders induced by silica nanoparticle through the AMPK signaling pathway. Sci. Total Environ. 2021;762:143152.
  • Yin H, Li J, Tian J, et al. Uterine pyruvate metabolic disorder induced by silica nanoparticles act through the pentose phosphate pathway. J Hazard Mater. 2021;412:125234.
  • Zamorski MA, Biggs WS. Management of suspected fetal macrosomia. Am Fam Physician. 2001;63(2):302–306.
  • Li J, Tian J, Yin H, et al. Chemical conjugation of FITC to track silica nanoparticles in vivo and in vitro: an emerging method to assess the reproductive toxicity of industrial nanomaterials. Environ Int. 2021;152:106497.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.